Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The genetic characterization of urothelial tumor disease has brought to light important information about the biology of the disease. The evaluation of molecular DNA markers on tumor tissue could be an approach able to provide important information on the possible aggressiveness of the disease and the sensitivity/resistance profile to drugs commonly adopted in the advanced stage. The main objective of this study is to identify specific molecular profiles from DNA capable of predicting the clinical course of the disease and the possible sensitivity/resistance of the disease to systemic treatments
Official title: Study for the Evaluation of Molecular Markers Extracted From PRedittivI DNA of Clinical Outcomes and Response to Systemic Therapy in Patients With UROthelial Tumor.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
210
Start Date
2023-03-01
Completion Date
2025-03-31
Last Updated
2025-03-07
Healthy Volunteers
No
Conditions
Locations (1)
IRCCS Azienda Ospedaliero Universitaria Bologna
Bologna, Italy